SPECTRAL MD, INC. - AWARD OF SPECTRAL MD'S DHA STTR SEQUENTIAL PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT OF DEVICE TO ENABLE THE ASSESSMENT OF BURN SEVERITY BY ARTIFICIAL INTELLIGENCE IN THE MILITARY'S ECHELON III CARE ENVIRONMENT"

On Dec 3, 2025, Department of Defense obligated $1,632,483.31 to SPECTRAL MD, INC. for award of spectral md's dha sttr sequential phase ii medical r&d contract for "development of device to enable the assessment of burn severity by artificial intelligence in the military's echelon iii c…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 1 offer received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in DALLAS, TX.